1330P Second-line nintedanib + docetaxel for patients with lung adenocarcinoma after first-line chemo-immunotherapy treatment: Updated efficacy and safety results from VARGADO Cohort C

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 32; pp. S1018 - S1019
Main Authors	Grohé, C., Wehler, T., Dechow, T., Henschke, S., Schütte, W., Dittrich, I., Hammerschmidt, S., Müller-Huesmann, H., Schumann, C., Krüger, S., Atz, J., Kaiser, R.
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.09.2021
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1016/j.annonc.2021.08.1931